Interestingly, in addition to the already described activities, HSP90 inhibitors were shown to exert barrier protective effects on pulmonary arterial endothelial cells and were suggested to have useful therapeutic value in ARDS and other pulmonary inflammatory diseases (Antonov et al., 2008). This evidence concerns the gene HSP90AA1 and acute respiratory distress syndrome.